Related Experiment Video

Updated: Jun 12, 2026

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
06:22

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

Published on: February 10, 2023

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination

Vytautas Usonis1, Ioana Anca, Francis André

  • 1Vilnius University Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. vytautas.usonis@mf.vu.lt

BMC Infectious Diseases
|June 16, 2010
PubMed

Insights

Universal influenza vaccination for children aged 6 months and older is recommended to reduce the significant health and economic burden of the flu. This strategy also offers indirect protection to vulnerable populations.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Influenza poses a significant threat to children, including healthy ones, often leading to complications.
  • The burden of influenza in young children is underestimated and exceeds that in elderly populations.
  • Current influenza vaccination practices often exclude healthy children, despite their susceptibility.

Purpose of the Study:

  • To provide guidance on influenza vaccination for infants and children.
  • To advocate for the widespread adoption of influenza vaccination in pediatric populations.
  • To reduce the health and economic impact of influenza in children.

Main Methods:

  • Guidance statement development by the Central European Vaccination Advisory Group (CEVAG).
  • Review of influenza epidemiology and vaccination benefits in children.
  • Formulation of recommendations for universal pediatric influenza vaccination.

Main Results:

  • Influenza vaccination benefits healthy children and reduces the overall disease burden.
  • Universal vaccination of children provides community-wide indirect protection.
  • Children up to 60 months of age are identified as a high-risk group.

Conclusions:

  • CEVAG recommends universal influenza vaccination for all children starting at 6 months of age.
  • Implementation strategies should be tailored to individual country circumstances.
  • Widespread vaccination of children is crucial for controlling influenza and its associated burdens.
Abstract

More Related Videos

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

Expression and Purification of Virus-like Particles for Vaccination06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...